Copyright
©The Author(s) 2022.
World J Exp Med. Jul 20, 2022; 12(4): 53-67
Published online Jul 20, 2022. doi: 10.5493/wjem.v12.i4.53
Published online Jul 20, 2022. doi: 10.5493/wjem.v12.i4.53
Figure 1 The 3 distinct pathways of complement activation (the classical complement pathway, the alternative complement pathway, and the lectin pathway) and complement inhibitors with potential use in reducing coronavirus disease 2019 related side effects.
Created with BioRender.com
- Citation: Gianni P, Goldin M, Ngu S, Zafeiropoulos S, Geropoulos G, Giannis D. Complement-mediated microvascular injury and thrombosis in the pathogenesis of severe COVID-19: A review. World J Exp Med 2022; 12(4): 53-67
- URL: https://www.wjgnet.com/2220-315x/full/v12/i4/53.htm
- DOI: https://dx.doi.org/10.5493/wjem.v12.i4.53